77 related articles for article (PubMed ID: 36054308)
1. Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease.
Vlasschaert C; McNaughton AJM; Chong M; Cook EK; Hopman W; Kestenbaum B; Robinson-Cohen C; Garland J; Moran SM; Paré G; Clase CM; Tang M; Levin A; Holden R; Rauh MJ; Lanktree MB
J Am Soc Nephrol; 2022 May; 33(5):985-995. PubMed ID: 35197325
[TBL] [Abstract][Full Text] [Related]
2. Clonal haematopoiesis and risk of chronic liver disease.
Wong WJ; Emdin C; Bick AG; Zekavat SM; Niroula A; Pirruccello JP; Dichtel L; Griffin G; Uddin MM; Gibson CJ; Kovalcik V; Lin AE; McConkey ME; Vromman A; Sellar RS; Kim PG; Agrawal M; Weinstock J; Long MT; Yu B; Banerjee R; Nicholls RC; Dennis A; Kelly M; Loh PR; McCarroll S; Boerwinkle E; Vasan RS; Jaiswal S; Johnson AD; Chung RT; Corey K; Levy D; Ballantyne C; ; Ebert BL; Natarajan P
Nature; 2023 Apr; 616(7958):747-754. PubMed ID: 37046084
[TBL] [Abstract][Full Text] [Related]
3. Clonal haematopoiesis and AKI.
Allison SJ
Nat Rev Nephrol; 2024 May; 20(5):271. PubMed ID: 38532004
[No Abstract] [Full Text] [Related]
4. Clonal haematopoiesis, ageing and kidney disease.
Vlasschaert C; Lanktree MB; Rauh MJ; Kelly TN; Natarajan P
Nat Rev Nephrol; 2024 Mar; 20(3):161-174. PubMed ID: 37884787
[TBL] [Abstract][Full Text] [Related]
5. Aging, Inflammation, and Comorbidity in Cancers-A General In Silico Study Exemplified by Myeloproliferative Malignancies.
Ottesen JT; Andersen M
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835500
[TBL] [Abstract][Full Text] [Related]
6. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
Hasselbalch HC; Junker P; Skov V; Kjær L; Knudsen TA; Larsen MK; Holmström MO; Andersen MH; Jensen C; Karsdal MA; Willumsen N
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686599
[TBL] [Abstract][Full Text] [Related]
7. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
Krecak I; Verstovsek S; Lucijanic M
Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
[TBL] [Abstract][Full Text] [Related]
8. Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.
Kjær L; Skov V; Larsen MK; Boklund TI; Andersen M; Kefala M; Knudsen TA; Schjellerup Eickhardt-Dalbøge C; Stiehl T; Gudmand-Høyer J; Snyder J; Holmström M; Andersen MH; Ottesen JT; Ellervik C; Hasselbalch HC
Front Oncol; 2023; 13():1176173. PubMed ID: 37223675
[TBL] [Abstract][Full Text] [Related]
9. Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ; Rashid M; Ahmed N; Nadeem M; Shamsi TS
Asian Pac J Cancer Prev; 2016; 17(3):923-6. PubMed ID: 27039813
[TBL] [Abstract][Full Text] [Related]
10. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2
Saki N; Shirzad R; Rahim F; Saki Malehi A
Clin Transl Oncol; 2017 Jul; 19(7):874-883. PubMed ID: 28205126
[TBL] [Abstract][Full Text] [Related]
11. Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up.
Larsen MK; Skov V; Kjaer L; Møller-Palacino NA; Pedersen RK; Andersen M; Ottesen JT; Cordua S; Poulsen HE; Dahl M; Knudsen TA; Eickhardt-Dalbøge CS; Koschmieder S; Pedersen KM; Çolak Y; Bojesen SE; Nordestgaard BG; Stiehl T; Hasselbalch HC; Ellervik C
Eur J Haematol; 2022 Nov; 109(5):576-585. PubMed ID: 36054308
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Hematological Relevance of JAK2V617F, CALR, and MPL Mutations in Vietnamese Patients with Essential Thrombocythemia.
Vu HA; Thao TT; Dong CV; Vuong NL; Chuong HQ; Van PNT; Nghia H; Binh NT; Dung PC; Xinh PT
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2775-2780. PubMed ID: 31554376
[TBL] [Abstract][Full Text] [Related]
13. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
Guo H; Chen X; Tian R; Chang J; Li J; Tan Y; Xu Z; Ren F; Zhao J; Pan J; Zhang N; Wang X; He J; Yang W; Wang H
PLoS One; 2015; 10(9):e0138250. PubMed ID: 26375990
[TBL] [Abstract][Full Text] [Related]
14. Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.
Lim KH; Chen CG; Chang YC; Chiang YH; Kao CW; Wang WT; Chang CY; Huang L; Lin CS; Cheng CC; Cheng HI; Su NW; Lin J; Chang YF; Chang MC; Hsieh RK; Lin HC; Kuo YY
Oncotarget; 2017 May; 8(20):32476-32491. PubMed ID: 28415571
[TBL] [Abstract][Full Text] [Related]
15. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
Pérez Encinas MM; Sobas M; Gómez-Casares MT; Abuin Blanco A; Noya Pereira MS; Raya JM; Andrade-Campos MM; Álvarez Larrán A; Lewandowski K; Łukasz S; Hernández Boluda JC; Ferrer-Marín F; Fox ML; Gołos A; Gasior Kabat M; Magro Mazo E; Czyż A; Martín Martín A; Bellosillo Paricio B; Quinteiro García C; González Martín JM; Stuckey R
Eur J Haematol; 2021 Mar; 106(3):371-379. PubMed ID: 33275803
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
